Legend Biotech (LEGN) Change in Inventory (2020 - 2026)
Legend Biotech's (LEGN) quarterly Change in Inventory came in at $700000.0 in Q1 2026, up 121.88% YoY from $315493.0 in Q1 2025, and down 86.97% on a QoQ basis from $5.4 million in Q3 2025.
Legend Biotech (LEGN) Change in Inventory (2020 - 2026) Analysis & Trends
Legend Biotech (LEGN) has 7 years of Change in Inventory data on file, last reported at $700000.0 in Q1 2026.
- Quarterly Change in Inventory rose 121.88% year-over-year to $700000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $53000.0 (up 100.33% YoY) and the FY2024 annual result came in at -$17.2 million, down 35.43% from the prior year.
- Change in Inventory retreated to $700000.0 in Q1 2026, from $5.4 million in the prior quarter.
- In the past five years, Change in Inventory ranged from a high of $5.4 million in Q3 2025 to a low of -$8.6 million in Q4 2022.
- A 5-year average of -$2.9 million and a median of -$3.2 million in 2023 frame the typical range for Change in Inventory.
- Annual changes were most pronounced in 2022 — Change in Inventory slumped 7382.61% — and 2025, when it surged 205.75%.
- Tracing LEGN's Change in Inventory over 5 years: stood at -$8.6 million in 2022, then soared by 56.98% to -$3.7 million in 2023, then tumbled by 69.23% to -$6.3 million in 2024, then soared by 185.76% to $5.4 million in 2025, then sank by 86.97% to $700000.0 in 2026.
- The last three Change in Inventory figures came in at $700000.0 (Q1 2026), $5.4 million (Q3 2025), and -$2.8 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 27.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 28.20 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 47.15 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -2,188.52 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -280,000.00 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 12.97 Mn |
| 10 | Legend Biotech | 3.95 Bn | 3.27 Bn | 251.50 Mn | -6.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -6.00 Mn |
| Jun 30, 2026 | -6.00 Mn |
| Mar 31, 2026 | 700,000.00 |
| Mar 31, 2026 | 700,000.00 |
| Sep 30, 2025 | 5.37 Mn |
| Sep 30, 2025 | 5.37 Mn |
| Jun 30, 2025 | -2.82 Mn |
| Jun 30, 2025 | -2.82 Mn |
| Mar 31, 2025 | -3.20 Mn |
| Mar 31, 2025 | -3.20 Mn |
| Dec 31, 2024 | -6.27 Mn |
| Dec 31, 2024 | -6.27 Mn |
| Sep 30, 2024 | -5.08 Mn |
| Sep 30, 2024 | -5.08 Mn |
| Jun 30, 2024 | -1.39 Mn |
| Jun 30, 2024 | -1.39 Mn |
| Mar 31, 2024 | -4.47 Mn |
| Mar 31, 2024 | -4.47 Mn |
| Dec 31, 2023 | -3.70 Mn |
| Dec 31, 2023 | -3.70 Mn |